GE HealthCare said revenue for Q4 2023 rose 5% year over year to $5.2 billion, and adjusted EBIT margin was 16.1% versus 17.1% a year earlier, down 100 basis points. Net income margin was 7.7% versus 11.2% in the prior year.

1. 01

   GE HealthCare said revenue for Q4 2023 rose 5% year over year to $5.2 billion, and adjusted EBIT margin was 16.1% versus 17.1% a year earlier, down 100 basis points. Net income margin was 7.7% versus 11.2% in the prior year.

2. 02

   GE HealthCare reported full-year 2023 net income attributable to GE HealthCare of $1,568 million, down from $1,916 million a year earlier, and diluted EPS from continuing operations of $3.04 versus $4.18. The company said both comparisons were affected by standalone interest expense.

3. 03

   The company said cash flow from operating activities for full-year 2023 was $2,101 million and free cash flow was $1,715 million. It said it repaid $850 million of debt in Q4 2023 and an additional $150 million in January 2024.

4. 04

   GE HealthCare said its full-year 2024 guidance calls for organic revenue growth of approximately 4%, adjusted EBIT margin of 15.6% to 15.9%, adjusted EPS of $4.20 to $4.35, and free cash flow of approximately $1.8 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.